Momentum grows to change medical supply chain from China

Calls are growing for the U.S. to reduce its dependence on China for key medicines and supplies as Americans face widespread shortages in the midst of the coronavirus pandemic.

While the U.S. supply chain’s heavy reliance on Beijing for medical manufacturing has been glaringly apparent for roughly two decades, both lawmakers and administration officials say the virus has exposed just how vulnerable the country is as it leans on China and other nations to help provide the tools necessary to combat the pathogen.

Peter Navarro, President Trump’s economic adviser, pledged this week that the United States would move away from its reliance on other nations and toward building up its own capabilities to produce drugs and medical supplies. Continue reading.